AC Immune SA (ACIU) Fundamentals

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.
SHARE INFORMATION
Market CapUS$ 262,958,891
Shares Outstanding83,552,294
Float39,372,786
Percent Float47.16%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -1.06
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions115
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months2,333,074
Institutional Holdings Percent21.7%
Institutional Sold Previous 3 Months485,383
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week HighUS$ 12.61
52 Week LowUS$ 2.46
52 Week High ChangeUS$ -50.70
21 Day Moving AverageUS$ 3.1776
21 Day Extended Moving AverageUS$ 3.2498
50 Day Moving AverageUS$ 3.6908
50 Day Extended Moving AverageUS$ 3.572
200 Day Moving AverageUS$ 5.1152
200 Day Extended Moving AverageUS$ 4.8021
10 Day Average Volume135,167
20 Day Average Volume109,348
30 Day Average Volume92,155
50 Day Average Volume93,497
Alpha-0.009814
Beta0.8495
Standard Deviation0.168180
R20.057177
7 Day Price ChangeUS$ -0.05
7 Day Percent Change-1.56%
21 Day Price ChangeUS$ -0.37
21 Day Percent Change-10.51%
30 Day Price ChangeUS$ -0.67
30 Day Percent Change-17.54%
Month to Date Price ChangeUS$ -0.43
Month to Date Percent Change-12.01%
Quarter to Date Price ChangeUS$ -0.85
Quarter to Date Percent Change-21.25%
180 Day Price ChangeUS$ -2.20
180 Day Percent Change-41.12%
200 Day Price ChangeUS$ -4.18
200 Day Percent Change-57.03%
Year to Date Price ChangeUS$ -1.80
Year to Date Percent Change-36.36%

AC Immune SA (ACIU) Key Ratios

PROFITABILITY
EBIT Margin-7,498.6%
EBITDA Margin-7,255.5%
Pre-Tax Profit Margin-320.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.20
Total Debt To Equity0.00
Int Coverage-104.90
Current Ratio14.90
Leverage Ratio1.10
Quick Ratio14.60
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-3.00
Enterprise ValueUS$ 95,883,992
Price to Sales0.00
Price to Free Cash-3.30
PE High Last 5 Years19.70
Price To Book1.20
Price To Cash Flow8.90
PE Low Last 5 Years-43.90
Price to Tangible Book1.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-33.68
Return on Equity-37.03
Return on Capital-36.85

AC Immune SA (ACIU) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers AG
CEOAndrea Pfeifer
Emplyoees143
Last AuditUQ
CIK0001651625
IndustryBiotechnology
SectorHealthcare
NAICS-
CONTACT INFO
AddressEPFL Innovation Park
Building B
Lausanne, 1015
Websitehttps://www.acimmune.com
Facsimile+41 216939120
Telephone+41 216939121
Emailir@acimmune.com
Your Recent History
NASDAQ
ACIU
AC Immune
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20220528 10:12:32